GO:0071544 diphosphoinositol polyphosphate catabolic process: Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071544 describes the biochemical breakdown of diphosphoinositol polyphosphates (inositol pyrophosphates), signaling molecules with one or more diphosphate groups on the inositol ring.
• The catabolic process is carried out by specific phosphatases, including DIPP1 (NUDT3), DIPP2 (NUDT4), DIPP3 (NUDT10/11), and PPIP5K, which remove diphosphate groups to regenerate monophosphoinositol polyphosphates.
• Diphosphoinositol polyphosphates such as 5-IP7 and 1-IP7 regulate key cellular processes including insulin signaling, vesicle trafficking, and stress responses.
• Dysregulation of this catabolic pathway has been linked to obesity, cancer, and neurodegenerative conditions, making its enzymes potential therapeutic targets.
• Studying GO:0071544 requires tools such as CRISPR knockout models, nonhydrolyzable analogues, and advanced mass spectrometry to track inositol pyrophosphate turnover.
• EDITGENE provides CRISPR-based services to dissect the catabolic process, including knockout, point mutation, knock-in, and overexpression cell models for genes like NUDT3 and PPIP5K.
Description
Diphosphoinositol polyphosphates, also known as inositol pyrophosphates, are a family of highly phosphorylated inositol derivatives that function as signaling molecules in eukaryotic cells. The catabolic process that breaks them down, annotated as GO:0071544, is essential for terminating their signaling actions and recycling inositol polyphosphates. This process involves the enzymatic removal of diphosphate groups from molecules such as 5-diphosphoinositol pentakisphosphate (5-IP7) and 1-IP7, converting them back to less phosphorylated forms. Researchers study this pathway because it controls diverse physiological functions, from insulin secretion to cell death, and its dysregulation is implicated in human diseases including obesity and cancer. Understanding the enzymes and mechanisms of diphosphoinositol polyphosphate catabolism provides a foundation for therapeutic interventions targeting these signaling molecules.
diphosphoinositol polyphosphate catabolic process At A Glance
| GO ID | GO:0071544 |
|---|---|
| GO term | diphosphoinositol polyphosphate catabolic process |
| Ontology | biological_process |
| Synonym | diphosphoinositol polyphosphate breakdown, diphosphoinositol polyphosphate catabolism, diphosphoinositol polyphosphate degradation |
| Major function | Breakdown of diphosphoinositol polyphosphates (inositol pyrophosphates) to regulate their cellular levels and signaling |
| Key enzymes | NUDT3 (DIPP1), NUDT4 (DIPP2), NUDT10/11 (DIPP3), PPIP5K |
| Substrates | 5-IP7, 1-IP7, and other diphosphoinositol polyphosphates |
| Cellular location | Cytoplasm and nucleus |
| Related processes | Inositol phosphate metabolism, signal transduction, insulin secretion |
What Is GO:0071544?
GO:0071544, diphosphoinositol polyphosphate catabolic process, is defined as the chemical reactions and pathways resulting in the breakdown of a diphosphoinositol polyphosphate, which is a 1,2,3,4,5,6-cyclohexanehexol with one or more diphosphate groups and multiple monophosphate groups attached. In simpler terms, it is the process by which cells degrade inositol pyrophosphates, a class of energy-rich signaling molecules, by removing their diphosphate groups. This catabolic process is crucial for maintaining the balance of inositol polyphosphates and preventing excessive signaling.
Why Is diphosphoinositol polyphosphate catabolic process Important in Cell Biology?
The catabolism of diphosphoinositol polyphosphates is critical for cellular homeostasis because these molecules act as potent signaling hubs that influence processes such as insulin sensitivity, vesicle trafficking, and apoptosis. Dysregulation of this catabolic process can lead to pathological states, including obesity and cancer, as evidenced by genetic associations and functional studies. Understanding the enzymes and regulatory mechanisms of GO:0071544 offers opportunities for therapeutic targeting in metabolic and proliferative diseases.
• Regulates insulin signaling and glucose homeostasis, with links to obesity and type 2 diabetes.
• Controls cell survival and apoptosis through modulation of inositol pyrophosphate levels.
• Influences vesicle trafficking and exocytosis, impacting neurotransmitter release and hormone secretion.
• Plays a role in stress responses and DNA repair pathways.
• Associated with cancer progression via effects on cell growth and migration.
• Implicated in neurodegenerative diseases such as prion disorders.
• Provides targets for drug development, as enzymes like NUDT3 are druggable.
• Essential for understanding inositol polyphosphate signaling networks.
• Enables research on metabolic disorders through genetic models.
• Facilitates development of nonhydrolyzable analogues as research tools.
What Happens During diphosphoinositol polyphosphate catabolic process?
Substrate Recognition and Binding
In simple terms: The enzymes that break down inositol pyrophosphates first grab onto the target molecule.
The catabolic process begins with the recognition of diphosphoinositol polyphosphates, such as 5-IP7, by specific phosphatases like NUDT3 (DIPP1) and PPIP5K. These enzymes possess active sites that accommodate the highly phosphorylated inositol ring, ensuring specificity for diphosphate groups over monophosphate groups. Structural studies have revealed that the binding involves multiple positively charged residues that stabilize the substrate.
Hydrolysis of Diphosphate Groups
In simple terms: The enzyme cuts off the diphosphate group, releasing energy and leaving a simpler molecule.
Once bound, the enzyme catalyzes the hydrolysis of the diphosphate group, typically at the 5-position or 1-position of the inositol ring. This reaction converts 5-IP7 to IP6 (inositol hexakisphosphate) and inorganic phosphate, or 1-IP7 to IP6, depending on the substrate. The hydrolysis is metal-dependent, often requiring magnesium ions for catalysis.
Product Release and Recycling
In simple terms: After cutting, the enzyme lets go of the products, which can be reused or further metabolized.
Following hydrolysis, the products, such as IP6 and phosphate, are released from the active site. IP6 can be recycled into other inositol polyphosphates or serve as a signaling molecule itself. The enzyme is then free to catalyze another round of degradation, maintaining cellular levels of diphosphoinositol polyphosphates.
Regulation of Enzyme Activity
In simple terms: The breakdown process is turned on or off by cellular signals.
The activity of catabolic enzymes is regulated by various factors, including substrate availability, post-translational modifications, and interacting proteins. For instance, PPIP5K can be phosphorylated, affecting its localization and activity. Additionally, cellular energy status and stress signals can modulate the expression of these enzymes.
Key Genes Involved in GO:0071544 diphosphoinositol polyphosphate catabolic process
The following genes encode enzymes and regulators directly involved in the catabolism of diphosphoinositol polyphosphates, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NUDT3 | Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1); hydrolyzes diphosphate groups | Associated with body mass index in obese Japanese women; target for metabolic studies |
| NUDT4 | DIPP2; similar phosphatase activity toward inositol pyrophosphates | Potential role in insulin signaling; knockout models available |
| NUDT10 | DIPP3 alpha; degrades diphosphoinositol polyphosphates | Linked to cancer cell proliferation; studied in knockout cells |
| NUDT11 | DIPP3 beta; isoform with overlapping functions | Research on redundancy with NUDT10; CRISPR models |
| PPIP5K1 | Bifunctional enzyme with kinase and phosphatase activity; synthesizes and degrades IP7 | Key regulator of inositol pyrophosphate turnover; knockout mice show metabolic defects |
| PPIP5K2 | Paralog of PPIP5K1; also involved in IP7 metabolism | Studied for roles in vesicle trafficking and insulin secretion |
| IP6K1 | Inositol hexakisphosphate kinase 1; synthesizes IP7, opposing catabolism | Knockout mice display insulin sensitivity; target for diabetes research |
| IP6K2 | Inositol hexakisphosphate kinase 2; produces IP7 | Involved in apoptosis; studied in cancer models |
| IP6K3 | Inositol hexakisphosphate kinase 3; synthesizes IP7 | Brain-specific functions; knockout models for neurodegeneration |
| ITPK1 | Inositol-tetrakisphosphate 1-kinase; upstream in inositol phosphate pathway | Affects substrate availability for catabolism; knockout studies |
| MINPP1 | Multiple inositol polyphosphate phosphatase 1; can degrade IP6 and IP7 | Role in endoplasmic reticulum; knockout models |
| INPP5A | Inositol polyphosphate-5-phosphatase A; acts on inositol phosphates | Indirectly affects diphosphoinositol polyphosphate levels |
| INPP5B | Inositol polyphosphate-5-phosphatase B; similar to INPP5A | Studied in vesicle trafficking |
| OCRL | Oculocerebrorenal syndrome of Lowe protein; phosphatase | Mutations cause Lowe syndrome; affects inositol metabolism |
| SYNJ1 | Synaptojanin 1; polyphosphoinositide phosphatase | Linked to Parkinson's disease; impacts inositol signaling |
| FIG4 | Phosphatidylinositol 3,5-bisphosphate 5-phosphatase | Mutations cause Charcot-Marie-Tooth disease; affects inositol lipids |
| NUDT12 | Nudix hydrolase 12; may act on diphosphoinositol polyphosphates | Emerging role in NAD metabolism; potential cross-talk |
| NUDT13 | Nudix hydrolase 13; putative inositol pyrophosphate phosphatase | Understudied; knockout models needed |
How Is diphosphoinositol polyphosphate catabolic process Regulated?
The diphosphoinositol polyphosphate catabolic process is regulated at multiple levels. Enzyme activity can be modulated by post-translational modifications such as phosphorylation, which affects subcellular localization and substrate access. Cellular energy status and stress signals influence the expression of catabolic enzymes, ensuring that inositol pyrophosphate levels are adjusted to metabolic demands. Additionally, the balance between synthesis by IP6K enzymes and degradation by NUDT and PPIP5K enzymes is critical for maintaining steady-state levels of these signaling molecules.
diphosphoinositol polyphosphate catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NUDT3 | Obesity, body mass index regulation | Knockout mouse, overexpression in adipocytes |
| PPIP5K1 | Metabolic syndrome, insulin secretion | Knockout mouse, CRISPR point mutation |
| IP6K1 | Type 2 diabetes, insulin sensitivity | Knockout mouse, tissue-specific KO |
| NUDT10/11 | Cancer cell proliferation | Knockout cancer cell lines, xenografts |
| MINPP1 | Endoplasmic reticulum stress, cancer | Knockout cell lines, overexpression |
Metabolic Disorders and Obesity
Genetic variants in NUDT3, a key enzyme in diphosphoinositol polyphosphate catabolism, have been associated with body mass index in obese Japanese women, suggesting a role in energy homeostasis. Dysregulation of inositol pyrophosphate turnover may contribute to insulin resistance and obesity, making this pathway a therapeutic target for metabolic diseases.
Cancer
Inositol pyrophosphates and their catabolic enzymes influence cell growth, survival, and migration. Altered expression of NUDT3 and PPIP5K has been observed in various cancers, and modulation of this pathway can affect tumor progression. Targeting the catabolic process may offer novel anticancer strategies.
Neurodegeneration
Inositol polyphosphates, including diphosphoinositol polyphosphates, have been implicated in prion propagation and neurodegenerative diseases. The catabolic process may influence protein aggregation and neuronal survival, as suggested by studies in yeast and mammalian models.
From diphosphoinositol polyphosphate catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NUDT3 loss alter inositol pyrophosphate levels? | NUDT3 knockout cell line (e.g., HEK293) via CRISPR |
| What is the effect of a specific NUDT3 mutation on catalysis? | Point mutation knock-in (e.g., catalytic dead) in cell lines |
| How does PPIP5K1 overexpression affect insulin signaling? | Overexpression cell model in pancreatic beta cells |
| Can we track diphosphoinositol polyphosphate catabolism in real time? | Tagged knock-in of NUDT3 with fluorescent protein |
| What is the role of NUDT10 in cancer cell growth? | Knockout in cancer cell lines (e.g., HeLa) and proliferation assays |
| Does IP6K1 knockout rescue metabolic defects? | Knockout mouse model and metabolic phenotyping |
How to Study the diphosphoinositol polyphosphate catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Levels of inositol pyrophosphates and products | Quantifying catabolic flux in cell extracts |
| CRISPR knockout screening | Genes affecting inositol pyrophosphate levels | Identifying novel regulators of catabolism |
| Nonhydrolyzable analogues | Enzyme specificity and signaling effects | In vitro mechanistic studies |
| Fluorescence microscopy | Subcellular localization of tagged enzymes | Live-cell imaging of catabolic dynamics |
| Western blot | Protein expression of catabolic enzymes | Validating knockout or overexpression models |
| qRT-PCR | mRNA levels of genes like NUDT3 | Assessing transcriptional regulation |
| Enzymatic assays | Phosphatase activity of recombinant enzymes | Kinetic characterization of mutants |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory complexes |
Mass Spectrometry for Inositol Pyrophosphate Quantification
Advanced mass spectrometry techniques, such as LC-MS/MS, allow precise measurement of diphosphoinositol polyphosphates and their catabolic products in cell extracts. These methods are essential for assessing enzyme activity and pathway flux in response to genetic or pharmacological perturbations.
CRISPR-Cas9 Knockout Screening
Genome-wide CRISPR knockout screens can identify genes required for diphosphoinositol polyphosphate catabolism. By selecting for cells with altered inositol pyrophosphate levels, researchers can uncover novel regulators and validate known enzymes like NUDT3.
Nonhydrolyzable Analogues for Mechanistic Studies
Synthetic nonhydrolyzable analogues of diphosphoinositol polyphosphates enable researchers to probe enzyme specificity and downstream signaling without the confounding effects of hydrolysis. These tools are valuable for dissecting the catabolic process in vitro and in vivo.
Fluorescence Imaging of Tagged Enzymes
Tagging catabolic enzymes with fluorescent proteins allows real-time visualization of their localization and dynamics within cells. This approach can reveal how the catabolic process is spatially regulated and how it responds to cellular signals.
How CRISPR Can Be Used to Study GO:0071544 diphosphoinositol polyphosphate catabolic process
Knockout
CRISPR-Cas9 knockout of genes such as NUDT3, NUDT4, or PPIP5K1 allows researchers to study loss-of-function phenotypes in diphosphoinositol polyphosphate catabolism. Knockout cell lines can be used to measure accumulation of inositol pyrophosphates and downstream signaling changes.
Point Mutation
Introducing specific point mutations in catalytic residues of catabolic enzymes (e.g., NUDT3) via CRISPR base editing or homology-directed repair enables precise dissection of enzymatic activity versus scaffolding functions. Such models are valuable for understanding structure-function relationships.
Knock-in
Knock-in of tagged versions of catabolic enzymes (e.g., GFP-NUDT3) allows real-time tracking of protein localization and dynamics. This approach can also be used to introduce disease-associated variants for functional studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like PPIP5K1 can elevate catabolic activity, helping to determine the effects of enhanced breakdown on cellular physiology and disease models.
How EDITGENE Supports diphosphoinositol polyphosphate catabolic process Research
Researchers studying diphosphoinositol polyphosphate catabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with changes in inositol pyrophosphate levels. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes such as NUDT3, PPIP5K1, and IP6K1 in the context of this catabolic process.
Contact EDITGENE today to design your custom CRISPR model for diphosphoinositol polyphosphate catabolic process research.
Frequently Asked Questions About diphosphoinositol polyphosphate catabolic process
What is GO:0071544?
GO:0071544 is the Gene Ontology term for the diphosphoinositol polyphosphate catabolic process, which describes the breakdown of inositol pyrophosphates by removing diphosphate groups.
What genes are involved in diphosphoinositol polyphosphate catabolic process?
Key genes include NUDT3, NUDT4, NUDT10, NUDT11, and PPIP5K1, which encode enzymes that hydrolyze diphosphoinositol polyphosphates.
What are diphosphoinositol polyphosphates?
They are inositol derivatives with one or more diphosphate groups, such as 5-IP7 and 1-IP7, that act as signaling molecules in cells.
Why is diphosphoinositol polyphosphate catabolism important?
It regulates levels of inositol pyrophosphates, which control insulin signaling, cell survival, and metabolism; dysregulation is linked to obesity and cancer.
Which enzymes degrade diphosphoinositol polyphosphates?
NUDT family phosphatases (DIPP1-3) and PPIP5K are the primary enzymes that catalyze the catabolic process.
How is diphosphoinositol polyphosphate catabolic process studied?
Researchers use mass spectrometry, CRISPR knockout models, nonhydrolyzable analogues, and fluorescence imaging to study this pathway.
What diseases are associated with defects in this pathway?
Obesity, cancer, and neurodegenerative conditions such as prion disorders have been linked to altered diphosphoinositol polyphosphate catabolism.
Can CRISPR be used to study diphosphoinositol polyphosphate catabolic process?
Yes, CRISPR knockout, point mutation, and knock-in models enable precise functional studies of genes involved in this pathway.
What is the role of NUDT3 in diphosphoinositol polyphosphate catabolism?
NUDT3 (DIPP1) hydrolyzes diphosphoinositol polyphosphates, and its variants have been associated with body mass index in obese women.
How does PPIP5K regulate inositol pyrophosphate levels?
PPIP5K has both kinase and phosphatase activities, allowing it to synthesize and degrade IP7, thus controlling the catabolic process.
Conclusion
The diphosphoinositol polyphosphate catabolic process (GO:0071544) is a critical pathway for regulating inositol pyrophosphate signaling, with profound implications for metabolic and proliferative diseases. Advances in CRISPR technology and analytical methods continue to unravel the enzymes and mechanisms involved, offering new opportunities for therapeutic intervention. EDITGENE's suite of CRISPR services supports researchers in dissecting this pathway with precision and efficiency.
References
- 1. Thomas MP et al.. 2014. The enzymes of human diphosphoinositol polyphosphate metabolism.. FEBS J 281(1):14-33 PMID: 24152294
- 2. Shears SB et al.. 2011. Diphosphoinositol polyphosphates: what are the mechanisms?. Adv Enzyme Regul 51(1):13-25 PMID: 21035493
- 3. Kitamoto A et al.. 2013. NUDT3 rs206936 is associated with body mass index in obese Japanese women.. Endocr J 60(8):991-1000 PMID: 23708086
- 4. Wickner RB et al.. 2018. Prion propagation and inositol polyphosphates.. Curr Genet 64(3):571-574 PMID: 29243174
- 5. Best MD et al.. 2010. Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: structure, synthesis, and development of probes for studying biological activity.. Nat Prod Rep 27(10):1403-30 PMID: 20714465
- 6. Wu M et al.. 2014. Elucidating diphosphoinositol polyphosphate function with nonhydrolyzable analogues.. Angew Chem Int Ed Engl 53(28):7192-7 PMID: 24888434
- 7. Shears SB et al.. 2013. Structural insight into inositol pyrophosphate turnover.. Adv Biol Regul 53(1):19-27 PMID: 23107997
- 8. Shears SB. 2015. Inositol pyrophosphates: why so many phosphates?. Adv Biol Regul 57:203-16 PMID: 25453220
